Growth Metrics

Gilead Sciences (GILD) EBT Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,085.00
Dec 31, 2025 -2,064.00
Sep 30, 2025 1,257.00
Jun 30, 2025 956.00
Mar 31, 2025 -390.00
Dec 31, 2024 1,596.00
Sep 30, 2024 -1,685.00
Jun 30, 2024 9,662.00
Mar 31, 2024 -9,033.00
Dec 31, 2023 -964.00
Sep 30, 2023 881.00
Jun 30, 2023 360.00
Mar 31, 2023 -702.00
Dec 31, 2022 -705.00
Sep 30, 2022 1,053.00
Jun 30, 2022 2,632.00
Mar 31, 2022 -1,278.00
Dec 31, 2021 -3,585.00
Sep 30, 2021 1,710.00
Jun 30, 2021 -602.00
Mar 31, 2021 1,080.00
Dec 31, 2020 1,190.00
Sep 30, 2020 7,035.00
Jun 30, 2020 -9,391.00
Mar 31, 2020 377.00
Dec 31, 2019 5,912.00
Sep 30, 2019 -6,918.00
Jun 30, 2019 -211.00
Mar 31, 2019 2,697.00
Dec 31, 2018 -3,007.00
Sep 30, 2018 1,067.00
Jun 30, 2018 -302.00
Mar 31, 2018 422.00
Dec 31, 2017 -2,064.00
Sep 30, 2017 -125.00
Jun 30, 2017 202.00
Mar 31, 2017 205.00
Dec 31, 2016 -346.00
Sep 30, 2016 44.00
Jun 30, 2016 -119.00
Mar 31, 2016 -616.00
Dec 31, 2015 -205.00
Sep 30, 2015 -88.00
Jun 30, 2015 -214.00
Mar 31, 2015 1,115.00
Dec 31, 2014 204.00
Sep 30, 2014 -1,010.00
Jun 30, 2014 690.00
Mar 31, 2014 2,333.00
Dec 31, 2013 -314.00
Sep 30, 2013 -8.00
Jun 30, 2013 174.00
Mar 31, 2013 -237.00
Dec 31, 2012 31.00
Sep 30, 2012 -112.00
Jun 30, 2012 1,101.00
Mar 31, 2012 -791.00
Dec 31, 2011 -874.00
Sep 30, 2011 -2.00
Jun 30, 2011 57.00
Mar 31, 2011 540.00
Dec 31, 2010 -960.00
Sep 30, 2010 -193.00
Jun 30, 2010 -407.00
Mar 31, 2010 348.00
Dec 31, 2009 266.00
Sep 30, 2009 361.00
Jun 30, 2009 -613.00